TransCode Therapeutics, Inc. (RNAZ) NASDAQ
8.21
-0.34(-3.98%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
8.21
-0.34(-3.98%)
Currency In USD
| Market Cap | 23.53M |
| Enterprise Value | 17.76M |
| P/E Ratio | -0.25 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.8 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.17 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -5.19 |
| Return On Equity | -6.85 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -534,857 |
| EBITDA | -16.19M |
| Net Income | -16.75M |
| Diluted EPS | -47.14 |
| Total Cash | 2.84M |
| Total Cash/Share | 3.4 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.6 |
| Book Value Per Share | 1.71 |
| 52-Week Change | -27.41 |
| 52-Week High | 22.04 |
| 52-Week Low | 6.08 |
| Moving Average 50 Days | 9.36 |
| Moving Average 200 Days | 9.91 |
| Average Volume | 211,103 |
| Shares Outstanding | 916,968 |
| % Held by Institutions | 0.09 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:28 |
| Last Split Date | May 15, 2025 |